FFA
GSK icon

Frazier Financial Advisors’s GSK GSK Stock Holding History

Frazier Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16K Sell
21
-59
-74% -$3.2K ﹤0.01% 609
2025
Q4 		$3.92K Buy
+80
New +$3.73K ﹤0.01% 497
2024
Q4 		– Sell
-215
Closed -$8.79K – 748
2024
Q3 		$8.79K Sell
215
-259
-55% -$10.6K 0.01% 404
2024
Q2 		$18.2K Buy
474
+239
+102% +$10.1K 0.01% 309
2024
Q1 		$10.1K Buy
235
+177
+305% +$7.3K 0.01% 410
2023
Q4 		$2.15K Buy
+58
New +$2.08K ﹤0.01% 665

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Frazier Financial Advisors's GSK Position: Q1 2026 in Review

Frazier Financial Advisors reduced its GSK (GSK) stake by 74% in Q1 2026, selling an estimated $3.2K and leaving 21 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #609.

Frazier Financial Advisors first reported a position in GSK in Q4 2023 and has held it in 6 quarters since. The position peaked at $18.2K in Q2 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Frazier Financial Advisors held 21 shares of GSK worth $1.16K as of Q1 2026.
  • Frazier Financial Advisors sold 59 GSK shares in Q1 2026, an estimated $3.2K.
  • GSK made up ﹤0.01% of Frazier Financial Advisors's portfolio in Q1 2026, its #609 holding.
  • Frazier Financial Advisors first reported a position in GSK in Q4 2023 and has held it in 6 quarters since.
  • Frazier Financial Advisors's GSK position peaked at $18.2K in Q2 2024.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.